Edges in Network
| Network | GSE18864_egf1520 - GSE18864 - SiGN-BN HC+Bootstrap |
| Network Description | Tumor expression data from neoadjuvant trial of cisplatin monotherapy in triple negative breast cancer patients |
| Node | HLA-G |
| Upstream (Parents) |
|---|
| (<<) ADRBK1 → HLA-G |
| (<<) ARAF → HLA-G |
| (<<) ATXN1 → HLA-G |
| (<<) CPD → HLA-G |
| (<<) DOCK9 → HLA-G |
| (<<) HLA-A → HLA-G |
| (<<) HLA-F → HLA-G |
| (<<) LRCH4 → HLA-G |
| (<<) MAP3K11 → HLA-G |
| (<<) MVK → HLA-G |
| Downstream (Children) |
|---|
| HLA-G → CCND3 (>>) |
| HLA-G → CORO1A (>>) |
| HLA-G → EMILIN2 (>>) |
| HLA-G → EPHB2 (>>) |
| HLA-G → ERBB3 (>>) |
| HLA-G → FAM100B (>>) |
| HLA-G → FKSG2 (>>) |
| HLA-G → FZD2 (>>) |
| HLA-G → GNA15 (>>) |
| HLA-G → ICAM2 (>>) |
| HLA-G → IFITM3 (>>) |
| HLA-G → INPP5D (>>) |
| HLA-G → ISG20 (>>) |
| HLA-G → LTB (>>) |
| HLA-G → MLKL (>>) |
| HLA-G → NAV2 (>>) |
| HLA-G → RAC2 (>>) |
| HLA-G → RYK (>>) |
| HLA-G → SEMA5B (>>) |
| HLA-G → STK17B (>>) |
| HLA-G → SYK (>>) |
| HLA-G → TMSB10 (>>) |
| HLA-G → UBE2L6 (>>) |
